• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medications during pregnancy and nursing is a challenge for women suffering from the condition. There aren't many studies regarding how exposure over time may affect the foetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication in utero do not develop neurological developmental disorders such as hearing or vision impairment seizures, febrile seizures or IQ impairment. The authors acknowledge that more high-quality studies are needed.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication must consider the benefits of taking it versus the risks for the fetus. Doctors don't have the data needed to give clear guidelines but they can provide information on the risks and benefits to assist pregnant women in making informed decisions.

A study published in Molecular Psychiatry found that women who used adhd medication weight loss uk medications during their early pregnancy did not have a significantly increased risk of fetal heart malformations or major birth defects that are structural. Researchers conducted a massive population-based case control study to compare the incidence of major structural defects in infants who were born to mothers who were taking stimulants during pregnancy. Pediatric cardiologists and clinical geneticists examined the cases to ensure an accurate case classification and to limit the possibility of bias.

However, the researchers' study was not without its flaws. Researchers were unable, in the first place to distinguish the effects of the medication from the disorder. This makes it difficult for researchers to determine if the small associations observed among the exposed groups were due to the use of medications, or if they were affected by the presence of comorbidities. In addition the researchers did not look at the long-term effects of offspring on their parents.

The study did reveal that infants whose mothers took ADHD medication during pregnancy were at slightly more risk of being admitted to the neonatal intensive care unit (NICU) than those who whose mothers did not take any medication or had cut back on their medications prior to or during pregnancy. The reason for this was central nervous system disorders. The higher risk of admission was not affected by the stimulant medications used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher risk of having to have caesarean sections or the baby was not scoring well on the Apgar scale (less than 7). These increases did not appear to be influenced by the kind of medication used during pregnancy.

The researchers suggest that the small risk associated with the use of adhd medication and pregnancy medications during early pregnancy could be offset by the higher benefit for both mother and child of continuing treatment for the woman's disorder. Physicians should talk to their patients about this issue and, if possible, help them improve coping skills which may reduce the impact of her disorder in her daily functioning and her relationships.

Interactions with Medication

As more women than ever are diagnosed with ADHD and being treated with medication, the issue of whether to continue or discontinue treatment during pregnancy is a question that doctors are having to confront. These decisions are often made without clear and reliable evidence. Instead, doctors have to consider their own expertise, the experience of other doctors, and the research that has been conducted on the subject.

In particular, the issue of possible risks to the infant can be difficult. The research on this issue is based on observations rather than controlled studies, and many of the findings are contradictory. Additionally, the majority of studies limit their analysis to live births, which can undervalue the serious teratogenic effects that can cause abortion or termination of the pregnancy. The study discussed in this journal club addresses these shortcomings by looking at data from both live and deceased births.

The conclusion: While certain studies have demonstrated a positive association between ADHD medications and the risk of certain birth defects, other studies have found no connection, and most studies demonstrate a neutral or slightly negative effect. In the end, a careful risk/benefit assessment is required in every instance.

It can be challenging, if not impossible for women suffering from ADHD to stop taking their medication. In a recent article in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of loneliness. Furthermore, a loss of medication can affect the ability to complete jobs and drive safely which are essential aspects of daily life for many people suffering from ADHD.

She suggests that women who aren't sure whether to continue taking the medication or stop due to pregnancy, educate their family members, coworkers, and their friends about the condition, the effects on daily functioning, and the benefits of continuing the current treatment regimen. It can also aid in ensuring that the woman feels supported in her struggle with her decision. Some medications can pass through the placenta. If a patient decides to not take her ADHD medication while breastfeeding, it is important to be aware that the medication could be transferred to the baby.

Risk of Birth Defects

As the use and use of ADHD drugs to treat symptoms of attention deficit disorder hyperactivity disorder (ADHD) is increasing, so does concern about the potential effects of these drugs on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this topic. Researchers used two massive data sets to study more than 4.3 million pregnancies and determine if stimulant medication use increased birth defects. Researchers discovered that although the overall risk is low, first-trimester ADHD medication exposure was associated with slightly higher risk of certain heart defects, such as ventriculoseptal defect.

The authors of the study didn't discover any link between early medication usage and other congenital anomalies, like facial deformities, or club feet. The results are in the same vein as previous studies that have shown the existence of a slight, but significant increase in cardiac malformations for women who began taking ADHD medication prior to the time of pregnancy. This risk increased during the latter part of pregnancy when many women stopped taking their medication.

Women who used ADHD medications in the first trimester of their pregnancies were also more likely to experience a caesarean section, a low Apgar score after delivery and a baby who needed breathing assistance at birth. The authors of the study could not eliminate bias due to selection because they limited the study to women without other medical conditions that could have contributed to the findings.

Researchers hope that their study will inform physicians when they see pregnant women. The researchers recommend that while discussing the risks and benefits are important, the decision on whether to continue or stop taking medication should be according to the severity of each woman's ADHD symptoms and her requirements.

The authors caution that, while stopping the medication is a possibility to think about, it isn't advised due to the high prevalence of depression and other mental problems among women who are pregnant or have recently given birth. Additionally, research suggests that women who stop taking their medication will have a tough time adjusting to a life without them after the baby is born.

Nursing

The responsibilities that come dealing with adhd without medication being a new mom can be overwhelming. Women who suffer from ADHD who have to deal with their symptoms while attending physician appointments, making preparations for the arrival of a child and adapting to new routines in the home are often faced with a number of difficulties. Many women opt to continue taking their ADHD medication during pregnancy.

The risk for breastfeeding infant is not too high since the majority of stimulant medications passes through breast milk at a low level. However, the frequency of exposure to medications by the newborn can vary depending on dosage, frequency it is administered and the time of the day the medication is administered. Additionally, different medications enter the infant's system differently through the gastrointestinal tract and breast milk and the impact of this on a newborn infant is not well understood.

Some doctors may decide to stop stimulant medication during a woman’s pregnancy due to the absence of research. This is a complicated decision for the patient, who must balance the benefits of continuing her medication against the potential dangers to the embryo. In the meantime, until more information is available, doctors should ask all pregnant patients about their history of buy adhd medication online uk and whether they are planning or taking to take medication during the perinatal period.

A growing number of studies have shown that the majority of women are able to safely continue their ADHD medication during pregnancy and while breastfeeding. In response, a growing number of patients are opting to do so. They have discovered, in consultation with their physicians that the benefits of continuing their current medication far outweigh any possible risks.

Women who suffer from ADHD who plan to breastfeed should seek advice from a specialist psychiatrist prior to becoming pregnant. They should review their medications with their doctor and discuss the advantages and disadvantages of continued treatment, including non-pharmacological strategies. Psychoeducation should also be provided to help women with adhd focus medication [More Support] understand their symptoms and the underlying disorder, learn about available treatments and to reinforce existing coping strategies. This should involve a multidisciplinary approach, which includes the GP as well as obstetricians, psychiatry and obstetricians. The pregnancy counselling should consist of the discussion of a plan for management for both the mother as well as the child, as well as monitoring for signs of deterioration and the need for adjustments to the medication regimen.